diabetes glp-1 vs sglt2 inhibitors receptor agonists in T2D Frontiers | A decade of

doi: 10.7326/M20-0864 58 VermaSBainSCHonoreJBFemJAnMEpRet al

A recent metanalysis [87] has assessed the impact of oral antidiabetic drugs (OADs) and GLP-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes, the findings indicated that, compared to placebo and OADs, only liraglutide significantly improved left ventricular diastolic function

Replacement of GLP-2R ECL1 by poly-alanine abolished the ability of GLP-2 to elicit cAMP response, while replacement by that of GLP-1R diminished its potency by 196-fold

Translating the findings directly to a Trulicity user requires caution

The Limulus Amebocyte Lysate (LAL) test is the standard method

Third, one of the biggest challenges in weight management is the rebound effect that can occur after discontinuing GLP-1 medication